Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncogenerix Inc.

Division of Fortovia Therapeutics Inc.
oncogenerixpharma.com

Latest From Oncogenerix Inc.

DARA Divests Diabetes Compound; Shifts Focus To Oncology

The North Carolina company has washed its hands of development-stage assets and now is ready to be a strictly commercial-stage company focused on oncology support products.

BioPharmaceutical Strategy

Deals Shaping the Medical Industry (2/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fortovia Therapeutics Inc.
  • Senior Management
  • Contact Info
  • Oncogenerix Inc.
    3069 Pionalelli Crescent
    Mt. Pleasant, SC 29466
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register